Updates in cardiac amyloidosis: a review

SM Banypersad, JC Moon, C Whelan… - Journal of the …, 2012 - Am Heart Assoc
Systemic amyloidosis is a relatively rare multisystem disease caused by the deposition of
misfolded protein in various tissues and organs. It may present to almost any specialty, and …

Cardiac amyloidosis

MW Bloom, PD Gorevic - Annals of Internal Medicine, 2023 - acpjournals.org
Amyloidosis is a pathologic and clinical condition resulting from the accumulation of
insoluble aggregates of misfolded proteins in tissues. Extracellular deposition of amyloid …

Epidemiology and clinical manifestations of cardiac amyloidosis

F Bajwa, R O'Connor, K Ananthasubramaniam - Heart failure reviews, 2022 - Springer
Cardiac amyloidosis, once considered a rare disease, has garnered significant attention
over the last few years due to three key reasons: first, increased recognition of this disease …

Evaluation and management of the cardiac amyloidosis

JB Selvanayagam, PN Hawkins, B Paul… - Journal of the American …, 2007 - jacc.org
Cardiac amyloidosis describes clinically significant involvement of the heart by amyloid
deposition, which may or may not be associated with involvement of other organs. The …

Canadian Cardiovascular Society/Canadian Heart Failure Society joint position statement on the evaluation and management of patients with cardiac amyloidosis

NM Fine, MK Davis, K Anderson, DH Delgado… - Canadian Journal of …, 2020 - Elsevier
Cardiac amyloidosis is an under-recognized and potentially fatal cause of heart failure and
other cardiovascular manifestations. It is caused by deposition of misfolded precursor …

AL (light-chain) cardiac amyloidosis: a review of diagnosis and therapy

RH Falk, KM Alexander, R Liao, S Dorbala - Journal of the American …, 2016 - jacc.org
The amyloidoses are a group of protein-folding disorders in which≥ 1 organ is infiltrated by
proteinaceous deposits known as amyloid. The deposits are derived from 1 of several …

Cardiac amyloidosis: a practical approach to diagnosis and management

P Kapoor, T Thenappan, E Singh, S Kumar… - The American journal of …, 2011 - Elsevier
Cardiac amyloidosis, the primary determinant of prognosis in systemic amyloidoses, is
characterized by infiltration of myocardium by amyloid protein resulting in cardiomyopathy …

[HTML][HTML] Cardiac amyloidosis: updates in diagnosis and management

D Mohty, T Damy, P Cosnay, N Echahidi… - Archives of …, 2013 - Elsevier
Amyloidosis is a severe systemic disease. Cardiac involvement may occur in the three main
types of amyloidosis (acquired monoclonal light-chain, hereditary transthyretin and senile …

[HTML][HTML] Cardiac amyloidosis

A Martinez-Naharro, PN Hawkins, M Fontana - Clinical Medicine, 2018 - ncbi.nlm.nih.gov
Systemic amyloidosis comprises an uncommon group of disorders caused by the
extracellular deposition of misfolded proteins in various organs. Cardiac amyloid deposition …

Current trends in diagnosis and management of cardiac amyloidosis

BL Esplin, MA Gertz - Current problems in cardiology, 2013 - Elsevier
Amyloidosis is a rare disease in which insoluble extracellular protein fibrils in β-pleated
sheets infiltrate multiple organs, causing organ dysfunction and failure. Amyloidoses are …